Fig. 7
From: DLGAP5 promotes lung adenocarcinoma growth via upregulating PLK1 and serves as a therapeutic target
Correlation between DLGAP5 expression and different clinicopathologic characteristics of LUAD. A–L Correlation between DLGAP5 expression and T stage (A), N stage (B), M stage (C), clinical stage (D), primary therapy outcome (E), gender (F), age (G), smoker (H), number_pack_years_smoked (I), OS event (J), DSS event (K) and PFI event (L). (*P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant)